BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Guan H, Xu Z, Du G, Liu Q, Tan Q, Chen Y, Chen S, Wu J, Wang F, Zhang J, Sun L, Xiao W. A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging. Materials Today Bio 2023. [DOI: 10.1016/j.mtbio.2023.100610] [Reference Citation Analysis]
2 Li D, Liu Q, Yang M, Xu H, Zhu M, Zhang Y, Xu J, Tian C, Yao J, Wang L, Liang Y. Nanomaterials for mRNA ‐based Therapeutics: Challenges and Opportunities. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10492] [Reference Citation Analysis]
3 Soltani F, Kamali H, Akhgari A, Ghasemzadeh Rahbardar M, Afrasiabi Garekani H, Nokhodchi A, Sadeghi F. Preparation and Characterization of a Novel Multiparticulate Dosage Form Carrying Budesonide-Loaded Chitosan Nanoparticles to Enhance the Efficiency of Pellets in the Colon. Pharmaceutics 2022;15. [PMID: 36678698 DOI: 10.3390/pharmaceutics15010069] [Reference Citation Analysis]
4 Chen X, Zhang H, Tian C, Jia J, Xie H. Multiscale Magnetic Hydrogel Robot with a Core–Shell Structure for Active Targeted Delivery. ACS Appl Polym Mater 2022. [DOI: 10.1021/acsapm.2c01555] [Reference Citation Analysis]